Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Net Margin: 2023-2025

Historic Net Margin for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to -2,623.53%.

  • CG Oncology's Net Margin rose 4482996.00% to -2,623.53% in Q3 2025 from the same period last year, while for Sep 2025 it was -6,828.37%, marking a year-over-year increase of 468172.00%. This contributed to the annual value of -7,729.50% for FY2024, which is 2550481.00% up from last year.
  • CG Oncology's Net Margin amounted to -2,623.53% in Q3 2025, which was up 96.04% from -66,263.46% recorded in Q1 2025.
  • In the past 5 years, CG Oncology's Net Margin registered a high of -2,623.53% during Q3 2025, and its lowest value of -2,249,000.00% during Q4 2023.
  • Over the past 3 years, CG Oncology's median Net Margin value was -17,028.83% (recorded in 2024), while the average stood at -288,170.62%.
  • Its Net Margin has fluctuated over the past 5 years, first skyrocketed by 224,202,675bps in 2024, then plummeted by 6,306,271bps in 2025.
  • CG Oncology's Net Margin (Quarterly) stood at -2,249,000.00% in 2023, then soared by 224,202,675bps to -6,973.25% in 2024, then surged by 4,482,996bps to -2,623.53% in 2025.
  • Its Net Margin was -2,623.53% in Q3 2025, compared to -66,263.46% in Q1 2025 and -6,973.25% in Q4 2024.